Since 2011, Novoxel® has been re-inventing fractional resurfacing to provide impressive clinical results, as published in over 25 peer-reviewed articles. The innovative, patented Thermo-Mechanical Action (TMA®) does not use radiation, which reduces risks for the operator and patient. Treatments do not require topical anesthesia and down-time is minimal. Learn about Tixel 2 and recently approved Tixel i at booth 104!